ストックスクリーナーアプリを入手
12.28
4.96%
0.58
Alvotech (ALVO) 最新ニュース
Teva and Alvotech gets FDA review acceptance for its proposed biosimilar to Eylea - MSN
Teva/Alvotech follow Amgen in launching biosimilar for J&J’s Stelara - MSN
Teva Pharma and Alvotech launch biosimilar to J&J's Stelara in US - MSN
Teva, Alvotech Launch SELARSDI, Stelara Biosimilar - Contract Pharma
Teva Pharma and Alvotech launch US biosimilar to J&J’s Stelara - PharmaLive
Teva Pharma and Alvotech launch US biosimilar to J&J's Stelara - MSN
Teva/Alvotech launch biosimilar for J&J Stelara (TEVA:NYSE) - Seeking Alpha
Teva, Alvotech announces U.S. availability of SELARSDI injection - TipRanks
Teva Pharma and Alvotech launch US biosimilar to J&J's Stelara -February 21, 2025 at 06:27 am EST - Marketscreener.com
Teva And Alvotech Announce Selarsdi(TM) Injection Now Available In The U.S. -February 21, 2025 at 06:07 am EST - Marketscreener.com
Teva Pharma and Alvotech launch Stelara biosimilar in US -February 21, 2025 at 06:09 am EST - Marketscreener.com
Teva and Alvotech Announce SELARSDI™ (ustekinumab-aekn) Injection Now Available in the U.S. - GlobeNewswire
FDA-Approved SELARSDI Launches: What Makes This Stelara® Alternative Different? - StockTitan
Alvotech (NASDAQ:ALVO) Stock Price Down 6.7%Here's What Happened - MarketBeat
Alvotech Eyeing US Aflibercept Biosimilar Approval This Year With FDA Acceptance - News & Insights
FDA To Review Teva and Alvotech Drug That Could Compete With Regeneron's Eylea - MSN
Teva and Alvotech advance biosimilar portfolio in USA - The Pharma Letter
FDA accepts BLA for Alvotech’s Eylea biosimilar AVT06 review - World Pharmaceutical Frontiers
FDA Accepts Alvotech/Teva’s Application for Eylea Biosimilar - Managed Healthcare Executive
FDA Accepts Alvotech’s Eylea Biosimilar for Review - Contract Pharma
Alvotech’s AVT06 Biosimilar Application Accepted by FDA - TipRanks
Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Application for AVT06, a Proposed Biosimilar to Eylea®? (Aflibercept) - Marketscreener.com
US FDA Accepts Alvotech, Teva's Biologics License Application for Eylea Biosimilar - Marketscreener.com
Alvotech and Teva’s BLA filing for AVT06 accepted by FDA - TipRanks
FDA To Review BLA For Alvotech's Proposed Biosimilar To EyleaQuick Facts - Nasdaq
Alvotech and Teva Pharmaceuticals Announce FDA Acceptance of Biologics License Application for AVT06, a Biosimilar Candidate to Eylea - Nasdaq
Alvotech And Teva Announce Filing Acceptance Of U.S. Biologics License Application - Marketscreener.com
Alvotech and Teva Announce Filing Acceptance of U.S. - GlobeNewswire
Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Application for AVT06, a Proposed Biosimilar to Eylea® (aflibercept) - Finansavisen
Alvotech (NASDAQ:ALVO) Coverage Initiated by Analysts at UBS Group - MarketBeat
UBS Initiates Coverage of Alvotech (ICSE:ALVO) with Buy Recommendation - Nasdaq
UBS maintains Alvotech stock Buy rating, $18 target By Investing.com - Investing.com Australia
UBS Initiates Coverage of Alvotech (ALVO) with Buy Recommendation - MSN
UBS maintains Alvotech stock Buy rating, $18 target - MSN
Alvotech initiated with a Buy at UBS - TipRanks
23,467 Shares in Alvotech (NASDAQ:ALVO) Bought by Tempus Wealth Planning LLC - MarketBeat
Alvotech (NASDAQ:ALVO) Shares Gap DownHere's Why - MarketBeat
Alvotech (NASDAQ:ALVO) Sees Strong Trading VolumeHere's What Happened - MarketBeat
Alvotech (NASDAQ:ALVO) Short Interest Update - MarketBeat
China Universal Asset Management Co. Ltd. Makes New $748,000 Investment in Alvotech (NASDAQ:ALVO) - MarketBeat
Alvotech (NASDAQ:ALVO) Shares Gap UpStill a Buy? - MarketBeat
FDA accepts Alvotech, Teva's BLAs for Simponi biosimilars - Drug Store News
Alvotech And Teva Announce Acceptance Of BLA For AVT05, A Golimumab Biosimilar - Marketscreener.com
Short Interest in Alvotech (NASDAQ:ALVO) Rises By 244.2% - MarketBeat
3.23%
3.94%
大文字化:
|
ボリューム (24 時間):